Ditumopa, Rudy D.
HRN: 20-19-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/10/2023
12/16/2023
IV
600mg
Q8
CAP MR; Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes